La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
KPC PharmaceuticalsInc Bilan de santé
Santé financière contrôle des critères 6/6
KPC PharmaceuticalsInc has a total shareholder equity of CN¥5.6B and total debt of CN¥855.0M, which brings its debt-to-equity ratio to 15.3%. Its total assets and total liabilities are CN¥9.8B and CN¥4.2B respectively. KPC PharmaceuticalsInc's EBIT is CN¥482.3M making its interest coverage ratio 29.4. It has cash and short-term investments of CN¥2.0B.
Informations clés
15.3%
Ratio d'endettement
CN¥855.01m
Dette
| Ratio de couverture des intérêts | 29.4x |
| Argent liquide | CN¥1.96b |
| Fonds propres | CN¥5.59b |
| Total du passif | CN¥4.23b |
| Total des actifs | CN¥9.82b |
Mises à jour récentes de la santé financière
Recent updates
KPC PharmaceuticalsInc (SHSE:600422) Will Pay A Larger Dividend Than Last Year At CN¥0.20
Jul 25
Investors Still Waiting For A Pull Back In KPC Pharmaceuticals,Inc (SHSE:600422)
Jun 25We Think KPC PharmaceuticalsInc (SHSE:600422) Can Stay On Top Of Its Debt
Jun 04KPC PharmaceuticalsInc's (SHSE:600422) Profits May Not Reveal Underlying Issues
Mar 28Analyse de la situation financière
Passif à court terme: 600422's short term assets (CN¥7.3B) exceed its short term liabilities (CN¥3.8B).
Passif à long terme: 600422's short term assets (CN¥7.3B) exceed its long term liabilities (CN¥429.1M).
Historique et analyse du ratio d'endettement
Niveau d'endettement: 600422 has more cash than its total debt.
Réduire la dette: 600422's debt to equity ratio has reduced from 24.1% to 15.3% over the past 5 years.
Couverture de la dette: 600422's debt is well covered by operating cash flow (94.9%).
Couverture des intérêts: 600422's interest payments on its debt are well covered by EBIT (29.4x coverage).